Here’s a polished VC-ready one-pager designed to position ActiPatch by BIEL BioElectronics as a compelling, AI-integrated MedTech investment opportunity:
ActiPatch: Reinventing Pain Relief Through AI Partnerships
Investment Summary
ActiPatch transforms chronic pain management with non-drug, wearable electroceutical technology. Now, BIEL is unlocking its full potential by integrating with leading AI healthcare platforms—converting real-world device usage into actionable insights, predictive analytics, and personalized care.
Why ActiPatch Now?
Massive Opportunity at the convergence of AI, digital health, and value-based care
Scalable Distribution via integration with Digital Therapeutics (DTx) and Remote Patient Monitoring (RPM) platforms
Recurring Revenue Potential through data monetization, personalized algorithms, and SaaS-like infrastructure
AI-Enabled Expansion Channels
Segment Partner Targets ActiPatch Advantage
MSK Digital Therapeutics Sword Health, Hinge Health, Kaia Health Enhance personalization with real-world pain data
RPM & CCM Platforms Biofourmis, Datos Health, Current Health AI-powered adherence, alerts & remote coaching
Healthcare Analytics / RWE OM1, Tempus, Innovaccer Generate real-world evidence for payers & providers
Business Model Evolution
Hardware + API SaaS: Secure ActiPatch Data API powering integrations
Data Monetization: Anonymized usage insights licensed for model development
Co-Innovation & IP: Predictive flare detection, personalization engines, outcome registries
Investment Use of Funds
Build interoperable API infrastructure
Scale AI integration pilots
Launch ActiPatch Outcomes Registry
Expand distribution through global digital health channels
The Ask
Seeking: Strategic funding to accelerate AI-platform integration, validate payer pathways, and scale personalized pain care globally.
ROI Drivers: ✔ Entry into 3 high-growth verticals ✔ SaaS-like margins on data layer ✔ Accelerated market adoption through AI co-branding and clinical evidence
ActiPatch: Reinventing Pain Relief Through AI Partnerships
Investment Summary
ActiPatch transforms chronic pain management with non-drug, wearable electroceutical technology. Now, BIEL is unlocking its full potential by integrating with leading AI healthcare platforms—converting real-world device usage into actionable insights, predictive analytics, and personalized care.
Why ActiPatch Now?
Massive Opportunity at the convergence of AI, digital health, and value-based care
Scalable Distribution via integration with Digital Therapeutics (DTx) and Remote Patient Monitoring (RPM) platforms
Recurring Revenue Potential through data monetization, personalized algorithms, and SaaS-like infrastructure
AI-Enabled Expansion Channels
Segment Partner Targets ActiPatch Advantage
MSK Digital Therapeutics Sword Health, Hinge Health, Kaia Health Enhance personalization with real-world pain data
RPM & CCM Platforms Biofourmis, Datos Health, Current Health AI-powered adherence, alerts & remote coaching
Healthcare Analytics / RWE OM1, Tempus, Innovaccer Generate real-world evidence for payers & providers
Business Model Evolution
Hardware + API SaaS: Secure ActiPatch Data API powering integrations
Data Monetization: Anonymized usage insights licensed for model development
Co-Innovation & IP: Predictive flare detection, personalization engines, outcome registries
Investment Use of Funds
Build interoperable API infrastructure
Scale AI integration pilots
Launch ActiPatch Outcomes Registry
Expand distribution through global digital health channels
The Ask
Seeking: Strategic funding to accelerate AI-platform integration, validate payer pathways, and scale personalized pain care globally.
ROI Drivers: ✔ Entry into 3 high-growth verticals ✔ SaaS-like margins on data layer ✔ Accelerated market adoption through AI co-branding and clinical evidence
1
